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Abstract
Background
An increase of plasma kynurenine concentrations, potentially bioactive metabolites of tryp-
tophan, was found in subjects with obesity, resulting from low-grade inflammation of the
white adipose tissue. Bariatric surgery decreases low-grade inflammation associated with
obesity and improves glucose control.
Objective
Our goal was to determine the concentrations of all kynurenine metabolites after bariatric
surgery and whether they were correlated with glucose control improvement.
Design
Kynurenine metabolite concentrations, analysed by liquid or gas chromatography coupled
with tandemmass spectrometry, circulating inflammatory markers, metabolic traits, and
BMI were measured before and one year after bariatric surgery in 44 normoglycemic and 47
diabetic women with obesity. Associations between changes in kynurenine metabolites
concentrations and in glucose control and metabolic traits were analysed between baseline
and twelve months after surgery.
Results
Tryptophan and kynurenine metabolite concentrations were significantly decreased one
year after bariatric surgery and were correlated with the decrease of the usCRP in both
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groups. Among all the kynurenine metabolites evaluated, only quinolinic acid and xanthure-
nic acid were significantly associated with glucose control improvement. The one year delta
of quinolinic acid concentrations was negatively associated with the delta of fasting glucose
(p = 0.019) and HbA1c (p = 0.014), whereas the delta of xanthurenic acid was positively
associated with the delta of insulin sensitivity index (p = 0.0018).
Conclusion
Bariatric surgery has induced a global down-regulation of kynurenine metabolites, associ-
ated with weight loss. Our results suggest that, since kynurenine monoxygenase diverts the
kynurenine pathway toward the synthesis of xanthurenic acid, its inhibition may also contrib-
ute to glucose homeostasis.
Introduction
Obesity is often associated with systemic insulin resistance and low grade inflammation and an
immune activation of the adipose tissue that contributes to the development of metabolic and
vascular complications [1]. The inflammation state increases the activity of indoleamine
2,3-dioxygenase (IDO1) [2], a key enzyme that degrades the essential amino acid tryptophan
into kynurenine and initiates the kynurenine pathway that generates several metabolites collec-
tively called the “kynurenines” (Fig 1). Our group and others previously showed that obesity is
associated with an increased expression of the IDO1 gene in the human adipose tissue and with
increased concentrations of circulating kynurenines and kynurenine to tryptophan (K/T) ratio
reflecting the increased enzymatic activity of IDO1, that also correlates with the increased
expression of inflammatory markers in the adipose tissue [3–6]. We have also shown that
kynurenine concentrations were positively associated with BMI and the insulin resistance
index HOMA2-IR in a French general population cohort [7]. Tryptophan and kynurenine con-
centrations have already been shown to be correlated with HOMA-IR and HOMA-beta scores
in hepatitis C virus patients [8]. An association of kynurenine, kynurenic acid and quinolinic
acid with BMI and HOMA-IR was also recently demonstrated in another cohort [9].
Gastric banding and Roux-en-Y bypass are common bariatric surgery procedures [10]. Bar-
iatric surgery improves the inflammation of the adipose tissue and decreases the concentra-
tions of circulating inflammatory markers [11]. However, the metabolic effect of bariatric
surgery is not fully understood and many patients may remain diabetic or insulin resistant
after surgery despite significant weight loss through gastric banding [12].
Our objective was first to characterize the impact of surgical weight loss on the obesity-asso-
ciated kynurenine pathway dysregulation and to determine whether kynurenines contribute to
glucose homeostasis. In this study, we assessed the long term effects of weight loss on kynure-
nine pathway metabolite (KPm) concentrations and on metabolic traits in diabetic and normo-
glycemic women with severe obesity one year after bariatric surgery.
Subjects and Methods
Study design and characteristics of participants
One hundred subjects enrolled in ABOS (Biological Atlas of Severe Obesity, ClinicalGov
NCT01129297) were included in a previous study which evaluated circulating kynurenines in
obese women [7]. The present work aims at determining tryptophan and kynurenine metabolite
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concentrations one year after bariatric surgery. After one year follow-up, data for ninety one
participants were available (Fig 2). The selection criteria were previously described [7]. Briefly,
since circulating tryptophan and kynurenine metabolite concentrations were shown to be signif-
icantly different between men and women [13] and in order to avoid gender effect, we studied
only women, which are more prone to undergo bariatric surgery. Participants had severe obesity
(BMI = 46,3 ±6,3 kg/m2) and met the criteria for bariatric surgery, as previously described [6].
We excluded non-Caucasian patients, family-related patients, smoking patients, patients with
cancer history or insulin treatment for diabetes. Among the 47 diabetic patients, 39 were given
an anti-diabetic therapy at inclusion; only 17 out of those 39 treated patients still had anti-dia-
betic therapy one year after surgery.
Written informed consent was obtained and the experimental design was approved by the
Ethics Committee of the University Hospital of Lille, France. Clinical and biological features
were assessed prospectively, first preoperatively and then 1 year after surgery. Relevant clinical
and metabolic characteristics of the 91 participants are described in Table 1. Women were clas-
sified into two groups. According to the American Association of Diabetes, the oral glucose tol-
erance test criteria for normal glycaemia are fasting glucose concentrations (FG)< 5.5 mmol/L
and 2-h glucose< 7.7 mmol/L and for type 2 diabetes: FG 7 mmol/L or 2-h glucose 11.1
Fig 1. Schematic representation of the kynurenine pathway. IDO1, indoleamine 2,3-dioxygenase 1;
IDO2, indoleamine 2,3-dioxygenase 2; TDO2, tryptophan 2,3-dioxygenase; TPH1, Tryptophan hydroxylase
1; TPH2, Tryptophan hydroxylase 2; AFMID, arylformamidase; KMO, kynurenine 3-monooxygenase;
CCBL1, kynurenine aminotransferase I; AADAT, kynurenine aminotransferase II; CCBL2, kynurenine
aminotransferase III; KYNU, kynureninase; HAAO, 3-hydroxyanthranilate 3,4-dioxygenase; QPRT,
quinolinate phosphoribosyl transferase; ACMSD, aminocarboxymuconate semialdehyde decarboxylase.
doi:10.1371/journal.pone.0158051.g001
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Fig 2. Flow chart of participants.
doi:10.1371/journal.pone.0158051.g002
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mmol/L. At inclusion, cases with type 2 diabetes were matched with normoglycemic controls
on age and BMI. Patients with missing follow-up data were excluded from the final analysis.
Overall, 47 women were diabetic and 44 were normoglycemic at inclusion and no significant
difference for age and BMI between the two groups of remaining patients was observed
(Table 1). The choice between laparoscopic adjustable gastric banding (AGB) [12] or Roux-en-
Y gastric bypass (RYGB) [14] was left to the surgical candidates after having been informed
about the risks and benefits of each procedure according to contemporary knowledge. 24 indi-
viduals (16 normoglycemic and 8 diabetic) chose AGB and 67 individuals (28 normoglycemic
and 39 diabetic) chose RYGB. The homeostasis model assessment (HOMA) was used as an
index of insulin sensibility (HOMA2-S) and β-cell function (HOMA2-B) and the product
of HOMA2-B and HOMA2-S was used as an index of β-cell compensatory capacity [15].
HOMA2-B and HOMA2-S were calculated using the HOMA calculator (https://www.dtu.ox.
ac.uk/homacalculator/).
Determination of serum tryptophan and kynurenine concentrations
Fasting serum samples were collected before and 12 months after surgery. Paired samples of
the same individual were analysed simultaneously. An analytical protocol based on liquid
chromatography coupled with tandem mass spectrometry (LC-MS/MS) was used to measure
tryptophan, serotonin, kynurenine, kynurenic acid, xanthurenic acid, 3-hydroxy-L-kynure-
nine and 3-hydroxy-anthranilic acid, as previously described [7]. Briefly, protein precipitation
was performed with acetonitrile, containing tryptophane-D5 (50μM, CDN isotopes, Pointe-
Claire, Canada) as an internal standard, and samples were injected onto an UPLC-MS/MS
Table 1. Clinical characteristics of diabetic (DB) or normoglycemic (NG) womenwith obesity from the ABOS cohort at inclusion (M0) and 12
months after surgery (M12).
M0 M12
DB (n = 47) NG (n = 44) DB (n = 47) NG (n = 44)
Age, years 47.2 ± 5.8 44.9 ± 7.1 48.2 ± 5.8 45.9 ± 7.1
Weight, kg 125.3 ± 18.4 126.3 ± 20.2 91.3 ± 17.2 94±18.0
Weight loss, % NA NA 26.9 ± 11.4 † 25.0 ± 12.4 †
BMI, kg/m2 47 ± 6.1 45.5 ± 6.4 34.2 ± 5.9 † 34.0 ± 6.7 †
usCRP, mg/L 7.2 ± 3.1 6.9 ± 3.3 2.6 ± 2.8 † 3.3 ± 3.3 †
HbA1c, % 7.2 ± 1.4 5.8 ± 0.3* 5.9 ± 0.7 † 5.6 ± 0.3* †
Fasting glucose, mmol/L 8.1 ± 2.9 5.4 ± 0.4* 5.6 ± 1.7 † 4.9 ± 0.5* †
2H glucose, mmol/L 12.6 ± 4.6 6.0 ± 1.2* 5.8 ± 3.6 † 5.2 ± 1.8 †
Fasting insulin, pmol/L 100.1 ± 58.9 81.2 ± 36.4 56.2 ± 81.0 † 41.1 ± 25.0 †
HOMA2-S,% 84.0 ± 149.1 79.7 ± 37.8 176.4 ± 118.6 † 179.2 ± 104.7 †
HOMA2-B,% 69.0 ± 44.8 108.2 ± 34.0* 70.1 ± 28.5 78.5 ± 26.3 †
HOMA2-BS, % 38.6 ± 23.0 76.5 ± 19.0* 104.9 ± 53.8 † 121.6 ± 44.8 †
Surgery (AGB/RYGB) 7/40 15/29 7/40 15/29
Remission (Yes/No) NA NA 29/18 NA
Data are presented as mean ± SD,
* p < 0.05 t-test was used for statistical analyses between diabetic and normoglycemic women at M0 and M12.
† p < 0.05 paired t-test was used for statistical analyses between baseline and at 12 months after surgery.
usCRP, ultrasensitive C Reactive Protein;
AGB, adjustable gastric banding;
RYGB, Roux-y-Gastric Bypass
doi:10.1371/journal.pone.0158051.t001
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system (Acquity TQ Detector, Waters, Milford, MA) equipped with a HSS C18 column. Ions
of each analysed compound were detected in a positive ion mode using multiple reaction
monitoring. Picolinic acid and quinolinic acid were simultaneously measured using gas chro-
matography-tandem mass spectrometry (GC-MS/MS), as previously described [7]. Briefly,
samples were mixed with internal standards (QUIN-D3 and PIC-D4, 2 μM) and methanol for
protein precipitation. Samples were dried and then heated to allow derivatization with penta-
fluoropropionic anhydride (PFPA, Sigma Aldrich, Saint-Quentin Fallavier, France) and hexa-
fluoroisopropanol (HFIP, Sigma Aldrich). The obtained derivatives were dried and dissolved
in iso-octane and finally injected onto the GC-MS/MS equipment (Agilent 7890 coupled to
Waters Quattro Micro GC, RAB293). Chromalinks software (Waters™) was used for data
acquisition and processing.
Statistical analyses
Statistical Mann-Whitney test for non normal distribution, T-test, paired T-test and Spearman
correlation test were performed with the GraphPad Prism version 5.00 for Windows (Graph-
Pad Software, San Diego, CA). The statistical tests are described with each result; the threshold
of significance was set to p< 0.05.
A linear mixed model was used to assess the association between KPm concentrations and
the concentrations of ultrasensitive C-reactive protein (usCRP), an inflammatory marker. In a
second time, we used a multivariate linear regression model adjusted for weight loss to assess
the association between the metabolic trait variations and tryptophan, serotonin and KPm con-
centration changes. In this study, since the weight loss and the type of bariatric surgery are
confounding factors (T-test, p = 1.59x10-13), we chose to adjust our results for weight loss,
knowing that we were simultaneously adjusting for the effect of the type of bariatric surgery.
Variations after surgery were evaluated by the difference between concentrations at one year
and concentrations at baseline ([M12]–[M0]); for readability purposes, we will refer to this dif-
ference as delta (Δ). The analysed metabolic traits were fasting plasma glucose, fasting plasma
insulin, glycated hemoglobin A1c (HbA1c), the homeostasis model assessment of β-cell func-
tion (HOMA2-B) and of insulin sensitivity (HOMA2-S) and their product called HOMA2-BS.
We used a Benjamini-Hochberg correction for multiple testing; the threshold of significance
for corrected p-values was set to p< 0.05. Statistical analyses were performed using R version
3.0 (packages nlme and multtest).
Results
At baseline, age and BMI were not significantly different between the diabetic (N = 47) and
normoglycemic (N = 44) groups (Table 1). Mean BMI significantly decreased one year after
bariatric surgery in both groups (p< 0.001) (Table 1). We observed a 25% decrease of the ini-
tial body weight in the group of normoglycemic women vs 26.9% in diabetic women (not sig-
nificant). As expected, fasting glucose and insulin concentrations, HOMA2-S, HOMA2-BS and
usCRP concentrations were significantly improved twelve months after bariatric surgery in
both groups (Table 1). We defined the rate of diabetes remission at one year by the absence of
diabetes-specific treatment and fasting blood glucose concentrations< 6.1 mmol/L [16].
Among the 47 diabetic women at baseline, 29 were in remission 12 months after surgery
(62%). The rate of diabetes remission is different between the two types of intervention and is
of 50% (4/8) for AGB and of 64% (25/39) for RYGB, but this is not significant which is cer-
tainly due to the small sample size since only 8 out of the 47 diabetic patients chose AGB.
One year after surgery, tryptophan, kynurenine, kynurenic acid, xanthurenic acid and qui-
nolinic acid concentrations significantly decreased in combined groups (e.g. 91 patients
The Kynurenine Pathway after Bariatric Surgery
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analysed simultaneously; p = 2.2x10-10, p = 2.7x10-4, p = 1.3x10-4, p = 1.6x10-7 and p = 8.4x10-5
respectively) (Fig 3) or in each glycemic group analysed independently (data not shown).
Among the KPm which were analysed, only picolinic acid concentrations did not decrease
after the surgery. Conversely, serotonin concentrations and the ratio of serotonin over trypto-
phan increased 12 months after bariatric surgery (p = 2.1x10-5 and p = 1.3x10-5, respectively).
Linear mixed model analysis showed that tryptophan concentrations were negatively corre-
lated with C Reactive Protein concentrations (usCRP, β = -0.018; p = 0.0072) and that kynure-
nine and kynurenic acid concentrations were positively correlated with usCRP concentrations
(β = 0.019; p = 0.028 and β = 0.038; p = 4.21x10-2, respectively) (Table 2). The K/T ratio
decreased after bariatric surgery (p = 7.5x10-4) and was also positively correlated with usCRP
concentrations (β = 0.036; p = 1.1x10-4). In addition, we observed that serotonin and the
ratio of serotonin over tryptophan were negatively correlated with usCRP concentrations
(β = -0.055; p = 0.014; β = -0.069; p = 0.0032, respectively).
As it was demonstrated that metformin, the first-line medication for the treatment of type 2
diabetes, could inhibit TDO2, a key enzyme in tryptophan metabolism [17], we assessed the
potential impact of diabetes therapy (except insulin, as patients on insulin therapy were
excluded) on KPm concentrations. No association was demonstrated between any KPm con-
centration and the presence of metformin therapy, alone or together with other anti-diabetic
drug, either at inclusion or one year after surgery (data not shown).
KPm concentrations were not significantly different between the normoglycemic and dia-
betic groups, neither at inclusion, nor one year after surgery (Table 3). Women were then
Fig 3. Tryptophan, serotonin, KPm concentrations, K/T ratio and serotonin over tryptophan ratio in the serum of women with
obesity at inclusion and 12months after bariatric surgery.Data are presented as mean ± SD; Mann-Whitney test was used for statistical
analyses, * statistically significant at 0.05 after a Benjamini-Hochberg correction for multiple testing.
doi:10.1371/journal.pone.0158051.g003
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reclassified according to their diabetic status 12 months after surgery and regrouped into “dia-
betic12m” and “nondiabetic12m” categories. No significant differences in any KPm concentra-
tions was observed between the two reclassified groups (Table 3).
Patients with RYGB had a higher decrease of the initial body weight (30.75% in average)
than patients with AGB (12.64% in average) after one year (p-value of 1.59x10-13). In this
study, weight loss and the type of bariatric surgery are confounding factors. We have chosen to
display only the results after adjusting for weight loss in this study after assessing that associa-
tions obtained after adjusting for weight loss, for intervention or for both are globally equiva-
lent (data not shown). Associations between KPm and quantitative metabolic trait changes
after surgery were analysed after adjusting for weight loss. Quinolinic acid and xanthurenic
acid concentrations changes with time (Δ) were correlated with the Δ of the analysed quantita-
tive metabolic traits. Indeed, the Δ quinolinic acid was negatively correlated with Δ fasting glu-
cose (β = -1.311; p = 0.019) and with ΔHbA1c (β = -0.678; p = 0.014), and, conversely, the Δ
xanthurenic acid was negatively correlated with the ΔHOMA2-S (β = -113.4; p = 0.0018) and
ΔHOMA2-BS (β = -38.69; p = 0.0026) indexes (Table 4). As expected, the Δ quinolinic acid
over xanthurenic acid ratio was negatively correlated with the Δ fasting glucose (β = -1.098;
Table 2. Association between usCRP and serum concentration of tryptophan, kynurenine, kynurenic
acid, serotonin, K/T ratio and serotonin over tryptophan ratio.
usCRP,mg/L
β p-value
Tryptophan, mmol/L -0.018 7.2x10-3
Kynurenine, mmol/L 0.019 0.028
Kynurenic acid, mmol/L 0.038 0.042
K/T ratio 0.036 1.1x10-4
Xanthurenic acid, mmol/ -0.014 0.083
Quinolinic acid, mmol/L 0.021 0.067
Serotonin, mmol/L -0.055 0.014
Serotonin / tryptophan ratio -0.069 3.2x10-3
usCRP, ultrasensitive C Reactive Protein
β coefﬁcients from linear mixed models are shown and correlations in bold are statistically signiﬁcant at
0.05 after a Benjamini-Hochberg correction for multiple testing.
doi:10.1371/journal.pone.0158051.t002
Table 3. Association between diabetic status and serum concentration of metabolites and K/T ratio, at inclusion and one year after surgery. One
year after surgery, analysis was performed first according to women diabetic status at inclusion and then according to their diabetic status after
reclassification.
At inclusion One year after surgery One year after surgery
(reclassiﬁed)
β p-value β p-value β p-value
Tryptophan, mmol/L 0.0587 0.2943 0.0348 0.6041 -0.0354 0.6264
Kynurenine, mmol/L 0.0364 0.6227 -0.0522 0.5494 -0.0639 0.4982
Kynurenic acid, mmol/L 0.1018 0.6325 0.1636 0.4288 -0.3710 0.0879
K/T ratio -0.0224 0.7810 -0.0870 0.3754 -0.0285 0.7888
Xanthurenic acid, mmol/L 0.0482 0.4862 -0.0232 0.7516 0.0090 0.9094
Quinolinic acid, mmol/L 0.2203 0.0991 0.0800 0.5608 -0.2204 0.1367
Serotonin, mmol/L -0.2045 0.5564 -0.1333 0.6220 0.1438 0.6259
doi:10.1371/journal.pone.0158051.t003
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p = 0.0075) and positively correlated with the improvement of the HOMA2-S (β = 91.12;
p = 0.00074) and HOMA2-BS (β = 27.09; p = 0.00082) indexes (Table 4).
Discussion
Our study shows that the K/T ratio significantly decreases after bariatric surgery-induced
weight loss. A previous study performed on 22 individuals did not demonstrate any significant
decrease of the K/T ratio after bariatric surgery [3]. Recently, a decrease in tryptophan and
kynurenine concentrations was shown in 38 individuals after a caloric restriction-induced
weight loss, but the K/T ratio was not significantly modified [18]. These contradictory results
may be due to the small sample size and the insufficient statistical power of these previous stud-
ies. Our study revealed that tryptophan and KPm concentrations significantly decreased one
year after bariatric surgery and were correlated with the decrease of the well-known marker of
systemic inflammation usCRP. We hypothesized that in patients with obesity, K/T ratio is
mainly driven by IDO1 activity. However, we could not exclude that tryptophan might be con-
verted into kynurenine by cortisol-inducible TDO2 enzyme as well [19]. These results are in
line with our previous observations that kynurenine concentrations are higher in individuals
with obesity compared to lean patients [6] and that kynurenine and several other KPms are
positively correlated with BMI in women from the same cohort [7]. However, among the
KPms, picolinic acid concentrations did not decrease at 12 months after surgery, suggesting
that the synthesis of picolinic acid is not affected by weight loss. Accordingly, we previously
showed that the enzyme which catalyzes the synthesis of picolinic acid is not expressed in
the human adipose tissue [7] which may explain our current data obtained after adiposity
reduction.
Our results also revealed that serotonin synthesis increased one year after surgery, suggest-
ing that in this new energetic state tryptophan metabolism is derived preferably towards
serotonin rather than kynurenine synthesis. In the same way, it has been suggested that the
number of serotonin-expressing enteroendocrine cells increases in the rat after bariatric sur-
gery [20]. However, a limitation of our study is that we evaluated serotonin concentrations in
the serum which is less accurate than in platelets as there is a risk of platelet-derived serotonin
contamination during the preparation of serum [21].
The presumed mechanisms of action of RYGB and of AGB are multiple and thought to be
of different nature [22]. Malabsorption of nutriments, as well as dramatic changes in diet
Table 4. Correlations betweenmetabolic trait changes and KPm level changes after surgery.
Δ Quinolinic acid Δ Xanthurenic acid Δ Quinolinic acid /
xanthurenic acid
β p-value β p-value β p-value
Δ Fasting glucose, mmol/L -1.311 0.019 0.953 0.144 -1.098 0.0075
Δ Fasting insulin, pmol/L -1.85 0.441 5.34 0.052 -3.15 0.0713
Δ HbA1c, % -0.678 0.014 0.154 0.636 -0.431 0.035
Δ HOMA2-B, % 6.97 0.485 8.37 0.469 0.391 0.957
Δ HOMA2-S, % 68.92 0.0667 -133.4 0.0018 91.12 0.00074
Δ HOMA2-BS, % 21.22 0.059 -38.69 0.0026 27.09 0.00082
The difference between the levels at 12 months and at inclusion ([M12]–[M0]) was used to analyse the changes in metabolic traits and KPm levels. For
readability purposes, we refer to this difference as delta (Δ).
β coefﬁcients from multiple linear model are shown adjusted for weight loss and correlations in bold are statistically signiﬁcant at 0.05 after a Benjamini-
Hochberg correction for multiple testing
doi:10.1371/journal.pone.0158051.t004
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observed after surgery, are susceptible to impair tryptophan concentrations and it was shown
that other amino acid profiles were also modified after bariatric surgery [23]. In order to prop-
erly assess the effect of the type of bariatric surgery, we would have to study for instance
patients after comparable weight loss, independently of the delay after surgery. In our study,
after adjusting for post-surgery weight loss, we found a remaining significant association
between several KPm concentration changes and the improvement of glucose homeostasis, but
no significant association between diabetes remission and KPm concentrations. Indeed, the
ratio of quinolinic acid over xanthurenic acid is positively associated with better insulin sensi-
tivity and glucose control.
The enzyme kynurenine 3-monooxygenase (KMO) is located at a critical branching point
in the kynurenine pathway such that the inhibition of this enzyme by either pharmacological
or genetic means may shift the flux towards the formation of kynurenic acid rather than to the
synthesis of xanthurenic acid. The inhibition of KMO has suggested that KMO regulates the
production of downstream KP metabolites. We have previously shown that the adipose tissue
expression of KMO was associated with higher HbA1c in women with obesity and was
expressed preferentially in pro-inflammatory M1 macrophages [7]. Both the activation of
KMO and, consequently, the potential synthesis of xanthurenic acid may be deleterious to glu-
cose homeostasis. Vitamin B6 deficiency was shown to lead to a large increase in the generation
of xanthurenic acid [24]. Interestingly, vitamin B6 deficiency was demonstrated in obesity [25].
Patients undergoing bariatric surgery were sporadically supplemented in vitamins after the
intervention to avoid any deficiency; unfortunately we had no information on vitamin B6 con-
centrations in patients’ sera. The compliance to vitamin B6 supplementation may also be a fac-
tor modulating the levels of xanthurenic acid.
The relationship between kynurenine metabolites and type 2 diabetes, especially xanthure-
nic acid, has been suspected for a long time [26–27] and these observations were recommended
to be further investigated [28]. Xanthurenic acid has been described as a zinc chelator and may
interfere with insulin secretion [29]. More recently, some studies suggested the involvement of
KPm in the development of insulin resistance [8] and the increase of xanthurenic acid concen-
tration in type 2 diabetes [30]. However, regarding the small number and heterogeneity of
the patients (from both genders, older diabetic patients than control patients), the results of
these studies require confirmation. Moreover, it was clearly demonstrated in a huge cohort
(n = 7052) that age and gender are modulating factors of KPm concentrations [13].
Considering our data, although we observed no difference in KPm concentrations between
the diabetic and normoglycemic groups, after weight loss adjustment, we found that a preferen-
tial decreased activation of the xanthurenic acid branch was associated with glucose control
improvement one year after bariatric surgery.
In conclusion, we showed that tryptophan and KPm concentrations decreased after a bariat-
ric surgery in women with obesity, and our results suggest potential interactions between
kynurenine metabolite production, inflammation and glucose metabolism.
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